PKM and cancer: Treatment with DASA-58, which interferes with CAFs-induced PKM2 functional (i.e. enzymatic) inhibition, induces loss of lactate addiction and restores glucose dependency in cancer cells, although maintaining a respiratory phenotype sustained by glucose respiration.